We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current EVAX market cap is 6.03M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 507k | 51k | 154k | 3.02M |
| Operating Income | -5.76M | -135.06M | -4.4M | -4.58M | -1.73M |
| Net Income | -5.68M | -134.81M | 1.19M | -6.2M | -1.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 507k |
| Operating Income | -10.86M | -16.57M | -25.83M | -25.26M | -152.9M |
| Net Income | -11.2M | -15.02M | -24.53M | -23.17M | -152.41M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.94M | 86.93M | 22.65M | 15.23M | 15.19M |
| Total Liabilities | 14.68M | 118.82M | 20.05M | 13.98M | 15.11M |
| Total Equity | -2.73M | -31.89M | 2.6M | 1.25M | 74k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.08M | 11.97M | 40.16M | 22.03M | 86.93M |
| Total Liabilities | 1.72M | 4.93M | 7.73M | 13.72M | 118.82M |
| Total Equity | 9.36M | 7.04M | 32.44M | 8.3M | -31.89M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -124.8M | N/A | -8.99M | N/A |
| Investing | N/A | -651k | N/A | -3k | N/A |
| Financing | N/A | 72.89M | N/A | 11.39M | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.02M | -12.44M | -21.93M | -25.77M | -124.8M |
| Investing | -68k | -393k | -1.33M | -268k | -651k |
| Financing | 9.51M | 8.82M | 49.81M | 7.85M | 72.89M |
| Market Cap | 6.03M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 5.58M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1.79 (63.93%) |
| Company Name | Evaxion Biotech AS |
| Address |
dr. neergaards vej 5f horsholm 2970 |
| Website | https://www.evaxion-biotech.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
